SCHOTT Pharma

New York, we’re back – and ready to connect, exciting innovations, you won’t want to forget! 💡 Following a successful DCAT Week, our team is heading straight to the heart of the action for INTERPHEX Global 2025 in the Big Apple! 📅 When: April 1–3, 2025 📍 Where: Javits Center, NYC – Booth #3301 Meet our experts on-site: Mitch Bardenwerper, Andrew Crawford, PhD, Patrick Gordon, Scott Koehler, Matthew Kushner, Kelsey Lancon, Sladjan Maksimovic, Sandra Miletta Manera, Jens Gabriel, and Daniele Tartini. Make the most of the last day at INTERPHEX—stop by our booth. We're eager to dive into discussions about our latest innovations, from subcutaneous injections of large-volume biologics to the next-gen SCHOTT TOPPAC® Infuse polymer syringe system. Let’s discuss how we can shape the future of pharmaceutical manufacturing together.

🌟 The Pharmaversity® experience 🌟 Explore the 3 cornerstones for your professional growth: Knowledge, events, and expert-led training.   Swipe through to see what’s inside!   👉 Pharmaversity® Knowledge Hub – Essential knowledge and in-depth data and insights 👉 Pharmaversity® Events – Premium events and global conferences 👉 Pharmaversity® Academy – Live webinars and customized workshops   🚀 Take your pharmaceutical know-how to the next level. 👩🎓👨🎓 Dive into Pharmaversity® now: https://lnkd.in/eNnnuybq

Let's talk about large-volume pre-filled syringes! 💉   Meet SCHOTT Pharma’s Dr. Sven Pohle, Global Product Manager Glass Syringes, at the 11th Pre-Filled Syringes, Injection Devices & Parenteral Systems Summit in Vienna, Austria.   📅 Date: April 2-3, 2025 📍 Venue: MAXX by Steigenberger Vienna   On April 3, 2025, from 9:35 a.m. to 10:10 a.m., Dr. Sven Pohle will hold a session on a stakeholder-centered development of a large-volume pre-filled syringe (PFS) for auto-injector use.   His key topics: 🔹 Why is large-volume subcutaneous drug delivery on the rise? 🔹 Which stakeholder requirements need to be considered in the development? 🔹 How was the interplay between the syringe and the device verified?   Discover the potential of large-volume PFS for auto-injector use and stay ahead of industry trends. See you in Vienna!

New York – here we go again! 🚀   Following the successful DCAT Week mid-March, our experts will return to the Big Apple for INTERPHEX. 📅 Date: April 1–3, 2025 📍 Place to be: Javits Center, NYC – #booth 3301   Join Mitch Bardenwerper, Andrew Crawford, PhD, Patrick Gordon, Scott Koehler, Matthew Kushner, Kelsey Lancon, Sladjan Maksimovic, Robert Meisenhelter III, Sandra Miletta Manera, Tony Perry, and Daniele Tartini on-site. They look forward to discussing our product innovations, including subcutaneous injections of large-volume biologics and our next-generation SCHOTT TOPPAC® infuse polymer syringe system. Let's shape the future of pharmaceutical manufacturing together.   We are delighted to meet you there! ✨

Let's shape the future of our industry together. Don't miss the Alliance for RTU at PDA Week!🚀 Are you attending PDA Week 2025 in Palm Springs, USA, from April 7 to 11? Join the Alliance for RTU Think Tank U.S. opening event on April 9, from 3:30 – 5:00 pm, as they present “Collaborating to innovate: advancing quality and efficiency with ready-to-use vials and cartridges.” Be part of an insightful discussion with moderator Richard Johnson, MSc, Immediate Past President and CEO of PDA - Parenteral Drug Association, featuring experts from pharma and CDMOs who will share the benefits of adopting ready-to-use (RTU) setups for manufacturing your drug products. Hear from Victor Bradford, Director of PSDPE Drug Product at Regeneron, about the strategic advantages of using RTU containers. Listen to what Mihaela Carmen Simianu, Ph.D, Vice President of R&D and Operations at Singota Solutions, shares about flexibility and speed to market. Get insights from Dhaval Patel, MS-Pharm Mfg/Eng, Director MS&T at INCOG BioPharma Services, Inc., about RTU packaging benefits and cost savings. Engage in this interactive session and enjoy a networking reception afterward with your peers. Secure your free spot now! 👉 https://lnkd.in/eKJ8F_t7

Shaping the future of pharmaceutical packaging - together with PDA - Parenteral Drug Association🚀 The PDA Parenteral Packaging Conference in Malaga, Spain, is in full swing—bringing together industry leaders for exciting discussions, groundbreaking innovations, and fresh perspectives! On Day 2, our experts Diana Löber, Christoph Zauner, Joan Castells Salvat and Tony Perry are engaging in dynamic conversations and forward-thinking solutions. SCHOTT Pharma is on-site, demonstrating its commitment to advancing the next generation of parenteral packaging. 📍 Visit us at Booth 14 to explore our latest patient-focused innovations for subcutaneous delivery of large-volume biologics, including: ✔ cartriQ® 10 ml ✔ syriQ BioPure® 5.5 ml ✔ Next-gen SCHOTT TOPPAC® infuse polymer syringes See you at the SCHOTT Pharma booth! 🤝

Why are syringes still packed in plastic blisters when a more sustainable solution exists? 🌱 Packaging waste and lack of storage capacity are two substantial challenges for hospitals. Bulky, single-use plastic packaging creates waste and needs a lot of storage room. How can we decrease these challenges? That's why SCHOTT Pharma and its Alliance to Zero partners Schreiner Group and Körber Pharma have developed a new packaging concept for prefilled syringes that reduces plastic and packaging waste. The new SCHOTT TOPPAC® infuse blister-free syringe concept allows the use of cartons instead of polymer blisters, which are easier to open for nurses and doctors, less space-consuming for disposal, and easier to recycle. Blister-free packaging minimizes waste and reduces space as well as the CO2 footprint. 📦 3 times less storage space in hospitals* 🗑️ 80 % or 500 kg less plastic and packaging waste* 🌱 20 % more syringes per container results in up to 58 % lower CO2 footprint during transport*   This blister-free syringe concept marks a significant milestone in the journey towards more sustainable pharmaceutical packaging, setting a new standard for the industry. Redefining safety, efficiency, and sustainability with the next-generation SCHOTT TOPPAC® infuse. https://lnkd.in/dDputdRs *All numbers are valid for 151.200 units of one sort for a 5 ml SCHOTT TOPPAC® infuse syringe. Given values are valid for best-case scenarios. PCF data are not considered.

Speed up your drug development with the right platform packaging. 🚀   Did you know that choosing the right vial early in the development process can significantly reduce risks and speed up your time-to-market? A “vial as a platform” approach allows pharmaceutical companies to work with pre-tested and pre-qualified packaging solutions, saving valuable time and resources.   👉 Discover how platform packaging accelerates development cycles and ensures drug stability: https://lnkd.in/esJutypB #PharmaceuticalPackaging #DrugDevelopment #UniqueVialExcellence #Efficiency #VialSolutions

No more red flags for your packaging. 🚩   SCHOTT Pharma's Core portfolio consists of high-quality drug containment solutions – cartridges, vials, and ampoules – manufactured with stringent quality controls and cGMP compliance. The container material is SCHOTT FIOLAX® Borosilicate Glass, which offers high chemical resistance for exceptional drug stability.   With Core, you are not just choosing standard containers but trusting reliability, consistency, and peace of mind. 💙 Quality is our ambition, far beyond manufacturing. Redefining the industry standard with our products so that medicines reach the patient in a safe, fast, and reliable manner. https://lnkd.in/epMFQ4kJ

15 years of innovation in parenteral packaging – what is next? 🚀   We look forward to this year's PDA Parenteral Packaging Conference in Malaga, Spain, from 25 to 26 March 2025. SCHOTT Pharma is on-site and delighted to showcase the key role it intends to play in driving innovation in parenteral packaging. Swing by SCHOTT Pharma at booth 14 to meet our experts and explore our innovative, patient-centered solutions for the subcutaneous delivery of large-volume biologics, including the cartriQ®10 ml, syriQ BioPure® 5.5 ml, and the next generation of SCHOTT TOPPAC® infuse polymer syringes.   Meet our experts on-site: 📌 Wednesday, 26 March; 08:00 – 08:45 Packaging science morning session, track A: PFAS in the life cycle of drug delivery devices Let's discuss the ECHA PFAS restriction proposal further: what does the restriction mean for you as a pharmaceutical, medical device, and supplier company? And what should you be doing now? Our Regional Director of Quality, Tony Perry, will moderate this round.   📌 Wednesday, 26 March; 09:00 – 10:20 Session 3 track A: Innovative solutions for packaging integrity Which innovative approaches ensure that the pre-filled syringe and cartridge packaging system provides appropriate protection for the drug product? From 09:30 – 09:40, there will be a presentation on “Syringe - functional label combinations: a symbiosis for product integrity” from our Head of Product Management Polymer Solutions, Christoph Zauner, and his co-presenter, Nadine Lampka, Dr. rer. nat., Senior Product Manager Pharma-Security at Schreiner Group. They will both take part in the subsequent Q&A discussion.   Let's continue to shape the future of packaging together. See you in Malaga!